53
Participants
Start Date
May 31, 2010
Study Completion Date
November 30, 2011
CNTO888+DOXIL®/ Caelyx® doxorubicin HCl liposome injection
10 mg/kg CNTO 888 every 2 weeks plus DOXIL®/Caelyx® (doxorubicin HCl liposome injection) 50 mg/m2 every 4 weeks
CNTO888 + gemcitabine
15 mg/kg CNTO 888 every 3 weeks plus gemcitabine 1000 mg/m2 administered on Days 1 and 8 of the 3-week cycle
CNTO888 + Paclitaxel and carboplatin
15 mg/kg CNTO 888 every 3 weeks plus paclitaxel 175 mg/m2 and carboplatin dosed to AUC 6 every 3 weeks
CNTO888 + docetaxel
15 mg/kg CNTO 888 every 3 weeks plus docetaxel 75 mg/m2 every 3 weeks
Detroit
Tacoma
Barcelona
Madrid
PAU de Sanchinarro
Lead Sponsor
Centocor, Inc.
INDUSTRY